Factors Affecting the Efficacy of Antiviral Treatment on Patients with HCV-related Cirrhosis

FENG Bo,LI Xiao-bo,FANG Ji-lian,MA Hui,RAO Hui-ying,SONG Guang-jun,WU Nan,WANG Hao,WEI Lai
DOI: https://doi.org/10.3969/j.issn.1007-8134.2012.02.012
2012-01-01
Abstract:Objective To investigate the factors affecting the efficacy of antiviral treatment on patients with HCV-related cirr-hosis.Methods The patients with HCV-related cirrhosis receiving antiviral treatment based on interferon(IFN) α were enrolled in the study.Epidemiological data,laboratory indicators at baseline and antiviral protocols were collected.The rate of sustained virological response(SVR) and the factors affecting SVR rate were analyzed.Results Of 28 eligible patients with HCV-related cirrhosis receiving IFN α combined with ribavirin,9(32.1%) obtained SVR.The ratio of males to females,age,infection duration,HCV RNA level,ALT/AST,absolute neutrophil count,HGB,PLT and Child-Pugh score at baseline in SVR group were not signi-ficantly different from those in non-SVR group(P 0.05).The SVR rate of patients receiving pegylated interferon(Peg-IFN) α was significantly higher than that of patients receiving IFN α(P=0.003),but the difference between them was not significant when excluding those patients discontinuing the therapy(P=0.308).The patients with good medication adherence had significantly higher SVR rate than those with poor medication adherence(P=0.004).The percentage of the patients terminating therapy with IFN α was significantly higher than that of the patients terminating therapy with Peg-IFN α(P =0.009).The percentage of the patients with high Child-Pugh scores was significantly higher than that of the patients with low Child-Pugh scores(P=0.034).Conclusions The SVR rate is low in patients with HCV-related cirrhosis,which is mainly associated with poor medication adherence,and the medication adherence is associated with the type of IFN and the severity of liver cirrhosis.
What problem does this paper attempt to address?